ACR Convergence 2025: New Gout Therapies in Phase III
Phase III studies at ACR Convergence 2025 reveal promising new gout therapies for patients with limited options or uncontrolled disease.
rheumatology.orgGout Gout is from Ipswich, Queensland, Australia. He was born there to parents who came from South Sudan before moving to Australia.[2][4]
Recent coverage says the Australian sprinter has been in strong form, including a 19.67-second 200m run at the Australian championships, which was reported as a world under-20 record.[4]
His family name was originally from South Sudanese spelling and pronunciation, but it was changed during transliteration after the family moved, which is why his surname is spelled “Gout.”[2]
Phase III studies at ACR Convergence 2025 reveal promising new gout therapies for patients with limited options or uncontrolled disease.
rheumatology.orgGout is a common and painful inflammatory arthritis caused by monosodium urate crystal deposition into joints in the setting of hyperuricemia. Recent reports indicate an increase in prevalence and incidence of gout worldwide. While genetics, dietary ...
pmc.ncbi.nlm.nih.govAustralian 18-year-old sprinter Gout Gout goes quicker than Usain Bolt did at the same age to win at his national championships.
www.bbc.co.ukAt ACR Convergence 2025, the American College of Rheumatology’s annual meeting, researchers presented pivotal phase 3 studies...
www.medicalindependent.ie